TABLE 1.
H. pylori strain used in inoculation | Time (wk) after inoculation | No. of grafts positive/total no. of grafts studied
|
|||
---|---|---|---|---|---|
Mucus
|
Antral mucosa
|
||||
Rapid urease test | Culture | Immuno-histochemistry | Culture | ||
LB1a | 2 | 2/2 | 2/2 | 2/2 | 2/2 |
4 | 2/2 | 2/2 | 2/2 | 2/2 | |
8 | 1/2 | 1/2 | 2/2 | 2/2 | |
12 | 1/2 | 1/2 | 2/2 | 2/2 | |
LB1b | 2 | 10/10 | 9/10 | 8/10 | 10/10 |
4 | 8/10 | 8/10 | 8/10 | 10/10 | |
8 | 6/10 | 6/10 | 9/10 | 10/10 | |
12 | 8/10 | 8/10 | 10/10 | 10/10 | |
ATCC 49503c | 2 | 1/5 | 1/5 | 1/5 | 1/5 |
4 | 0/5 | 0/5 | 0/5 | 0/5 | |
8 | 0/5 | 0/5 | 0/5 | 0/5 | |
12 | 0/5 | 0/5 | 0/5 | 0/5 | |
ATCC 49503d | 2 | 1/5 | 1/5 | 1/5 | 1/5 |
4 | 0/5 | 0/5 | 0/5 | 0/5 | |
8 | 0/5 | 0/5 | 0/5 | 0/5 | |
12 | 0/5 | 0/5 | 0/5 | 0/5 |
Grafts were inoculated with H. pylori LB1 freshly isolated from humans (two in vitro passages).
Grafts were inoculated with H. pylori LB1 after isolation from initially inoculated grafts (four in vitro passages).
Grafts were inoculated with H. pylori ATCC 49503 before in vivo passage in graft.
Grafts were inoculated with H. pylori ATCC 49503 after isolation from initially inoculated graft (four in vitro passages).